The Wasdell Group has received its Manufacturer’s / Importation Authorisation licence (MIA) for its new headquarters in Dundalk, Ireland. The site has now started operations.
Wasdell's Dundalk HQ is a custom-built 90,000sqft facility housing 11 bespoke production suites and temperature controlled high-bay warehouses and increases Wasdell’s capacity in clinical and commercial packaging, distribution and logistics and QP services.
"We are seeing a growing demand for our services, especially from companies that wish to outsource their entire product lifecycle from clinical services and EU launch to manufacturing, packaging and distribution. The new facility strengthens our offering, allowing us to further support our customers," said CEO Vincent Dunne.
Wasdell also has facilities in Swindon, Northampton and Newcastle in the UK, offering flexible and agile solutions to a growing customer base.
The Ireland site will support the company’s ongoing growth, while also allowing Wasdell to cement its presence in Europe in preparation for Brexit.
Dunne continued: “With over 75% of our turnover as export business, our new facility will serve our large client base in Europe and better support our growing US customer portfolio as they look to outsource their European supply chain operations from clinical projects to routine supply.”
The site also underwent a successful HPRA inspection in late 2018, which granted permission to perform QP batch certification and release of pharmaceutical products into Europe, further supporting Wasdell’s Brexit preparations.
Construction work started in September 2018 and Wasdell claims the facility "is thought to be the fastest custom-built site to achieve cGMP approval."
